IRINOTECAN, FOLINIC ACID, FLUOROURACIL, DOMVANALIMAB, FLUOROURACIL, ZIMBERELIMAB
PRODIGE 111
Phase 2 small_molecule active
Quick answer
IRINOTECAN, FOLINIC ACID, FLUOROURACIL, DOMVANALIMAB, FLUOROURACIL, ZIMBERELIMAB for stomach cancer, Esophage, gastro-oesophageal junction adenocarcinoma is a Phase 2 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- stomach cancer, Esophage, gastro-oesophageal junction adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active